Pharmaceutical Excipients Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends (2026-2035)

The pharmaceutical excipients market was valued at USD 12.25 Billion in 2025. It is poised to grow at a CAGR of 6.50% during the forecast period of 2026-2035, and reach USD 22.99 Billion by 2035. The market growth is driven by the rising demand for multifunctional excipients improving drug stability, bioavailability, and patient adherence. The growing shift toward biologics, sustained-release formulations, and personalized medicine is expected to enhance innovation and expand applications, supporting steady growth in the forecast period.

Latest News on the Pharmaceutical Excipients Market (2026)

• In March 2026, BASF Pharma Solutions announced up to 20% global price hike for excipients amid raw material cost pressure, supporting supply stability and boosting revenue growth in the market.
• In February 2026, DFE Pharma launched a continuous manufacturing platform with Gericke to enhance formulation efficiency, accelerating the adoption of advanced excipients and improving production scalability in the market.
• In August 2025, EXCiPACT asbl launched the revised 2025 Pharmaceutical Excipient Certification Standard, strengthening GMP, GDP, and GWP compliance. This enhances regulatory alignment and supply chain quality, boosting trust and supporting market growth.

Key Market Trends and Insights

• Based on formulation, the topical segment led 51% in the historical period market.
• By end user, pharmaceutical companies led 64% in the historical period market.
• Based on region, Europe dominated 33% in the historical period market.

Market Size & Forecast

• Market Size (2025): USD 12.25 Billion
• Projected Market Size (2035): USD 22.99 Billion
• CAGR (2026-2035): 6.50%
• Largest Market in 2025 : Europe

Pharmaceutical Excipients Market Overview

Pharmaceutical excipients play a vital role in modern drug formulation development, supporting stability, controlled release, and improved bioavailability. They are increasingly used in advanced dosage forms to enhance safety, efficacy, and patient compliance across various therapeutic applications worldwide. The market is driven by rising demand for advanced drug delivery devices, biologics, and oral solid dosage forms, with increasing focus on patient-centric formulations and regulatory compliance. The market is poised to grow at a CAGR of 6.50% during the forecast period of 2026-2035, supporting steady expansion across formulation and manufacturing segments.

Pharmaceutical Excipients Market Segmentation

Market Breakup by Product

• Organic Chemicals
• Carbohydrates
• Petrochemicals
• Oleochemicals
• Proteins
• Others
• Inorganic Chemicals
• Halites
• Metal Oxides
• Silicates
• Others

The market by product is divided into organic chemicals and inorganic chemicals, with organic excipients witnessing higher utilization due to their compatibility with advanced drug formulations and increasing demand for safer, high-performance pharmaceutical delivery systems across diverse therapeutic areas.

Market Breakup by Functionality

• Fillers & Diluents
• Binders
• Suspension and Viscosity Agents
• Coatings (Film & Enteric)
• Flavoring Agents
• Disintegrants
• Colorants
• Preservatives
• Others

The market by functionality includes fillers & diluents, binders, suspension and viscosity agents, coatings, flavoring agents, disintegrants, colorants, preservatives, and others, with rising emphasis on multifunctional excipients improving drug stability, controlled release, and patient-friendly dosage forms in modern formulations.

Market Breakup by Formulation

• Oral
• Parenteral
• Topical
• Ophthalmic Formulations
• Others

The market based on formulation spans oral, parenteral, topical, ophthalmic formulations, and others, with oral dosage forms dominating due to ease of administration, while parenteral and topical segments are expanding rapidly owing to biologics growth and advanced drug delivery innovations.

Market Breakup by Source

• Plant-Based
• Animal-Based
• Synthetic
• Mineral-Based
• Marine-Based

Segmentation by source covers plant-based, animal-based, synthetic, mineral-based, and marine-based excipients, where synthetic and plant-derived sources are increasingly preferred due to consistency, scalability, and regulatory compliance supporting high-quality pharmaceutical manufacturing globally.

Market Breakup by End Users

• Pharmaceutical Companies
• Research Organizations
• Academic Institutions
• Others

The market by end users is categorized into pharmaceutical companies, research organizations, academic institutions, and others, with pharmaceutical companies leading demand due to large-scale drug production, while research and academic sectors are contributing to innovation and formulation development.

Market Breakup by Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Regionally, the market is distributed across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa, with Asia Pacific showing strong growth potential driven by expanding pharmaceutical manufacturing, cost-effective production capabilities, and rising healthcare investments.

Pharmaceutical Excipients Market Growth Analysis and Key Influencers

Analysis Type

Factors

Example

Market Drivers

In February 2026, DFE Pharma launched a Continuous Manufacturing platform in Hyderabad with Gericke, enabling faster formulation optimization.

Market Restraints

Stringent regulatory compliance requirements increase costs, delays, and complexity due to diverse global standards and impurity testing rules.

P Dhinesh Pandian et al., 2025, highlighted inconsistent GMP enforcement and impurity testing gaps, limiting alignment with FDA, EMA, and ICH guidelines.

Market Opportunities

Expansion of indigenous manufacturing of complex excipients enhances domestic capability and reduces import dependency in pharmaceutical sector.

In June 2025, India’s Department of Science and Technology supported Nitika Pharmaceutical Specialties Pvt. Ltd. for 14 excipients.

Pharmaceutical Excipients Market Dynamics

The following section outlines the key factors influencing the growth of the market, including major drivers, restraints, and emerging opportunities.

Pharmaceutical Excipients Market Growth Drivers

Rising Adoption of Continuous Manufacturing Driving the Market Value

The market is driven by the increasing adoption of continuous manufacturing technologies that enhance formulation efficiency, scalability, and product quality. Pharmaceutical companies are increasingly focusing on advanced manufacturing systems to accelerate drug discovery and development and optimize lifecycle management. For example, in February 2026, DFE Pharma launched its continuous manufacturing platform in Hyderabad in collaboration with Gericke, integrating CM-ready excipients and modular processing systems. According to DFE Pharma, this initiative enables faster formulation optimization and data-driven development from early-stage exploration to large-scale production. Such advancements are expected to strengthen innovation in excipient design and support steady market expansion during the forecast period.

Pharmaceutical Excipients Market Restraints

Growing Focus on Regulatory Compliance and Quality Standardization in the Pharmaceutical Excipients Market

Stringent regulatory compliance requirements act as a key restraint in the market. Manufacturers must comply with varying global standards for quality, safety, impurity profiling, and documentation, which increases operational complexity, development costs, and approval timelines. These regulatory disparities limit seamless market entry and slow product commercialization. According to P Dhinesh Pandian et al., 2025, gaps in enforcement, lack of mandatory Good Manufacturing Practice compliance, and inconsistent impurity testing standards create quality variability and hinder alignment with global frameworks such as the FDA, EMA, and ICH guidelines, ultimately restricting market growth and international competitiveness.

Pharmaceutical Excipients Market Opportunities

Expansion of Indigenous Manufacturing of Complex Excipients Creates Growth Potential for the Market

Increasing focus on domestic production of complex pharmaceutical excipients is expected to create strong growth potential for the market. Rising demand for advanced drug formulations and active pharmaceutical ingredients is encouraging the development of high-quality, tailor-made excipients that enhance stability and delivery. For example, in June 2025, the Technology Development Board supported M/s Nitika Pharmaceutical Specialties Pvt. Ltd. for manufacturing 14 complex excipients domestically. This initiative reduces import dependency, strengthens local capabilities, and supports the expansion of advanced pharmaceutical ingredient manufacturing.

Pharmaceutical Excipients Market Trends

The market is witnessing several trends, including localized manufacturing expansion and strategic acquisitions.

Growing Adoption of Localized Pharmaceutical Manufacturing Strengthening Supply Chain Efficiency and Driving Market Growth

The rising adoption of localized manufacturing is likely to elevate market growth. The increasing development of regional production infrastructure is strengthening supply chain reliability and enhancing healthcare supply chain management, thereby supporting market growth. In November 2025, Clariant invested CHF 80 million to expand its pharmaceutical excipients facility in China, enhancing production capacity and ensuring a consistent supply of formulation ingredients. This development supports faster delivery, regulatory compliance, and manufacturing strength, boosting market value.

Rising Strategic Acquisitions to Accelerate the Pharmaceutical Excipients Market Innovation

Increasing integration of companies through acquisitions is expected to accelerate innovation in the market. Expansion of excipient portfolios is strengthening drug formulation capabilities in the market. In May 2025, Roquette completed the acquisition of IFF Pharma Solutions, enhancing its expertise in excipients and drug delivery systems. This strategic consolidation improves formulation efficiency and supports the development of patient-centric medicines, driving sustained market growth and long-term value creation.

Pharmaceutical Excipients Market Share

Oral Formulation Segment is Expected to Lead the Pharmaceutical Excipients Market

Among all, the oral formulation segment is expected to lead the market during the forecast period due to its wide patient acceptance, ease of administration, and suitability for chronic disease management through solid dosage forms such as tablets and capsules. The growing demand for improved drug stability, solubility, and bioavailability is further supporting its expansion. For example, in October 2023, Clariant launched new high-performance excipients at CPHI Barcelona to enhance API stability and solubility in oral drug delivery systems, highlighting increasing innovation in this segment. These advancements are expected to strengthen oral formulations as a dominant growth driver in the market.

Pharmaceutical Excipients Market Analysis by Region

The regions included in the report are North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Europe is expected to lead due to strong biopharmaceutical manufacturing and excipient innovation. For instance, in March 2026, Croda International Plc, a United Kingdom-based company, launched BioXPro amino acid range, enhancing bioprocessing applications. In November 2025, Amino GmbH, a Germany-based company, partnered with Croda to strengthen the high-purity amino acid supply for pharmaceutical formulation. These developments reinforce Europe’s dominance in advanced pharmaceutical excipients and biomanufacturing capabilities.

Leading Players in the Pharmaceutical Excipients Market

The key features of the market report comprise patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

BASF SE

BASF SE is a key participant in the market, offering advanced excipients and active pharmaceutical ingredients such as ibuprofen and omega-3 fatty acids. The company develops solutions for oral, topical, and parenteral formulations, focusing on drug delivery efficiency and biologics manufacturing. Its recent digital tools and pharma platforms support improved formulation development and regulatory compliance.

Ashland Global Holdings Inc.

Ashland Global Holdings Inc. is actively involved in the pharmaceutical excipients market, providing polymers, cellulose-based binders, coatings, and controlled-release agents for oral and injectable formulations. The company supports drug delivery innovation through customized excipient solutions and expanded injectable portfolios, enhancing bioavailability, stability, and patient compliance across global pharmaceutical applications.

DuPont de Nemours, Inc.

DuPont de Nemours, Inc. contributes to the pharmaceutical excipients market through ion exchange resin-based functional excipients used in controlled release, taste masking, and drug stability. Its AmberLite and Duolite product lines support formulation performance for poorly soluble drugs, improving therapeutic efficiency and patient adherence in oral drug delivery systems.

Roquette Frères S.A.

Roquette Frères S.A. is engaged in the pharmaceutical excipients market with plant-based excipients and capsule solutions designed for oral dosage forms. Its products improve solubility, stability, and taste masking while supporting direct compression and rapid disintegration. The company focuses on patient-friendly formulations and efficient manufacturing for global pharmaceutical applications.

Other key players in the market are Evonik Industries AG, Kerry Group Plc, Air Liquide S.A., Croda International Plc Innophos Holdings, Inc., and The Lubrizol Corporation.

Key Questions Answered in the Pharmaceutical Excipients Market Report

• What was the pharmaceutical excipients market value in 2025?
• What is the pharmaceutical excipients market forecast outlook for 2026-2035?
• What major factors aid the demand for the Pharmaceutical Excipients market?
• How has the market performed so far, and how is it anticipated to perform in the coming years?
• What are the market's major drivers, opportunities, and restraints?
• What are the major pharmaceutical excipients market trends?
• Which product is expected to dominate the market segment?
• Which functionality is projected to lead the market segment?
• Which formulation is anticipated to drive the market segment?
• Which source is likely to dominate the market segment?
• Which end users is expected to dominate the market segment?
• Who are the key players in the pharmaceutical excipients market?
• What are the current unmet needs and challenges in the market?
• How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?